You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 1, July 4, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Statistics and Research Methods
 •Randomized Controlled Trial
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Eligibility Criteria of Randomized Controlled Trials

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The study of the eligibility criteria of randomized controlled trials (RCTs) in high-impact general medical journals by Dr Van Spall and colleagues1 addresses a crucial issue for everyday clinical practice. Patients are often located in an area of "therapeutic uncertainty," since they would theoretically not have been eligible for any of the treatments tested in the clinical trials. Evidence comes from studies in the fields of cardiology, oncology, and psychiatry.2-4

It would be useful to know if the authors observed any independent association between the total number of exclusion criteria and positive results of an RCT. Such a correlation would cast more doubt on the transferability of RCT results to the target clinical population. In addition, in the multivariate analysis of the total number of exclusion criteria, the authors took into account the percentage of strongly, poorly, and potentially justified criteria; it would be more informative to . . . [Full Text of this Article]

Giorgio Costantino, MD; Elisa Ceriani, MD
celisa78@virgilio.it

Anna Maria Rusconi, MD; Nicola Montano, MD, PhD
Division of Internal Medicine II
Department of Clinical Sciences
L. Sacco Hospital
University of Milan
Milan, Italy



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Eligibility Criteria of Randomized Controlled Trials—Reply
Robert A. Fowler and Harriette G. C. Van Spall
JAMA. 2007;298(1):39-40.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.